2025
SJR Q2
JCR Q3 · 2
233 matched articles
SCIE
Journal detail
Journal of Vascular Access
- Publisher
- Wichtig Publishing Srl
- Country
- Italy · Western Europe
- Type
- journal
- ISSN
-
1129729817246032
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,532
- Quartile Q2
- H-Index 54
- Cites/doc 2,05
- Docs (3y) 672
- Cites (3y) 1.425
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2
- 5Y JIF 2,5
- JCI 0,34
WoS indexes
- SCIE
Subject classification
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,532 | 2 | 2,5 | 0,34 | Q4 | 54 |
| 2024 | Q2 | Q3 | 0,58 | 1,7 | 2,4 | 0,33 | Q4 | 51 |
| 2023 | Q2 | Q3 | 0,463 | 1,6 | 1,9 | 0,3 | Q4 | 51 |
| 2022 | Q2 | Q4 | 0,423 | 1,9 | 1,9 | 0,3 | Q4 | 51 |
| 2021 | Q2 | Q4 | 0,429 | 2,3 | 2,3 | 0,33 | Q4 | 51 |
| 2020 | Q2 | Q4 | 0,491 | 2,3 | 2,2 | 0,33 | Q4 | 51 |
| 2019 | Q3 | Q4 | 0,442 | 1,2 | 1,4 | 0,31 | Q4 | 51 |
| 2018 | — | Q4 | — | 1,4 | 1,4 | 0,3 | Q4 | — |
| 2017 | Q2 | Q4 | 0,545 | 1,3 | 1,3 | 0,31 | Q4 | 51 |
| 2016 | Q2 | Q4 | 0,502 | 1 | 1,1 | — | — | 51 |
| 2015 | Q2 | Q4 | 0,52 | 1,5 | 1,3 | — | — | 51 |
| 2014 | Q3 | Q4 | 0,369 | 0,8 | 1 | — | — | 51 |
| 2013 | Q2 | Q4 | 0,549 | 1 | 1,2 | — | — | 51 |
| 2012 | Q2 | Q4 | 0,46 | 1 | 1,1 | — | — | 51 |
| 2011 | Q2 | Q4 | 0,418 | 1,1 | — | — | — | 51 |
| 2010 | Q2 | Q4 | 0,371 | 0,8 | — | — | — | 51 |
| 2009 | — | Q4 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q4 | 63/100 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q4 | 68/98 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q4 | 65/96 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 52/68 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 52/67 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 49/65 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 60/65 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 56/65 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | Q4 | 54/65 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 62/63 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 48/63 |
| 2014 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 57/60 |
| 2013 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 58/65 |
| 2012 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 56/68 |
| 2011 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 55/68 |
| 2010 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 58/68 |
| 2009 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 50/61 |